Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pseudoephedrine blister-pack bill

This article was originally published in The Tan Sheet

Executive Summary

"Methamphetamine Blister Pack Loophole Elimination Act of 2003" (S 1784) was reported without amendment out of Senate Judiciary Committee and placed on the legislative calendar. Introduced by Sen. Dianne Feinstein (D-Calif.) a year ago, the measure would limit sales of pseudoephedrine to a 9 g threshold in an attempt to curb diversion of the ingredient to meth labs (1"The Tan Sheet" Oct. 27, 2003, In Brief). CHPA consistently has opposed similar bills, maintaining the limit will not prevent diversion and will harm retailers...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097388

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel